Yu Wang

Yu Wang

Auto-generated profile, based on publicly available information

Yu Wang

Department of Pediatrics, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
YWY. Wang
Y. Wang
SDS. Dai
S. Dai
XCX. Cheng
X. Cheng
EPE. Prado
E. Prado
LYL. Yan
L. Yan
LDlizhong du
lizhong du

1 December 2019 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
LYLingLing Yan
LingLing Yan
YWYu Wang
Yu Wang
ZZZiMing Zhang
ZiMing Zhang
SXShanShan Xu
ShanShan Xu
RURahim Ullah
Rahim Ullah
LDlizhong du
lizhong du


1 January 2025 in Case Reports in Infectious Diseases
Verified
Journal Article
Open access
YWYu Wang
Yu Wang
JHJun Hu
Jun Hu
FZFeng Zhu
Feng Zhu
LCLu Cheng
Lu Cheng
Hemophagocytic lymphohistiocytosis (HLH) is a critical and life‐threatening syndrome, which can rapidly progress to mortality without immediate or targeted therapeutic intervention. Human herpesvirus 8 (HHV‐8, or Kaposi sarcoma–associated herpesvirus (KSHV)) is a rarely described viral cause of secondary HLH, especially in immunocompetent adults. Here, we report an uncommon case of HLH after HHV‐8 infection, with no history of transplantation or HIV infection. The pathophysiological mechanisms of secondary HLH remain incompletely understood. There might be potential overlapping pathogenic pathways between HHV‐8‐associated HLH and KICS pathogenesis. E3 ubiquitin ligases may be a critical factor in the pathogenesis of HHV‐8‐associated secondary HLH. Ferritin testing, peripheral blood smears, and pathogenesis evaluations should be immediately implemented for patients presenting with fever and bicytopenia. Through our case report, we seek to advance clinical recognition of HHV‐8‐associated HLH, optimize diagnostic precision, and ultimately improve survival outcomes for patients.

14 July 2026 in Pulmonary Circulation
Verified
Journal Article
Open access
KCKewei Chen
Kewei Chen
LLLingchen Li
Lingchen Li
YHYajie Huang
Yajie Huang
LYLixia Ye
Lixia Ye
YWYu Wang
Yu Wang
LDlizhong du
lizhong du
Pulmonary hypertension (PH) is a chronic and devastating disease that currently lacks effective therapies, often ultimately requiring lung transplantation. Pulmonary vascular cells are subjected to various mechanical forces, which contribute to cardiovascular remodeling in PH. In recent years, Piezo ion channels have been instrumental in shaping the field of mechanobiology. However, a growing body of evidence underscores the critical role of Piezo channels in PH. As mechanosensitive channels, Piezo1 and Piezo2 directly transduce external mechanical stimuli into vascular cells and, as such, initiate intracellular biochemical cascades. Piezo ion channels contribute to the pathogenesis of pulmonary hypertension. In this review, we summarize the latest advances in Piezo channels research and focus on their role as key mechanotransducers in the progression of PH. Additionally, we explore the multifunctionality of Piezo channels in mechanobiology and propose new insights for preclinical animal studies and clinical trials. With a deeper understanding of Piezo‐mediated activation and modulation mechanisms, Piezo channels are emerging as promising therapeutic targets for the future treatment of PH.